BOULDER, Colo., Jan. 6, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO



    Event:     Annual J.P. Morgan Healthcare Conference

    Presenter: Ron Squarer, Chief Executive Officer, Array BioPharma

    Date:      Wednesday, January 13, 2016

    Time:      4:00 p.m. Pacific Time

    Location:  Westin St. Francis Hotel, San Francisco

    Webcast:   www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com. 



    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc.

                                    303-386-1193

                                    thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300199899.html

SOURCE Array BioPharma Inc.